Skip to main content
Michael Olek, DO, Neurology, Henderson, NV

MichaelJosephOlekDO

Neurology Henderson, NV

Neuroimmunology/Multiple Sclerosis

Associate Professor, Neurology, Touro University Nevada

Dr. Olek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Olek's full profile

Already have an account?

Summary

  • Dr. Michael Olek is a neurologist in Henderson, NV. He received his medical degree from Philadelphia College of Osteopathic Medicine and has been in practice 30 years. He is experienced in general neurology and neuroimmunology (multiple sclerosis).

Education & Training

  • Brigham and Women's Hospital/Harvard Medical School
    Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Neuroimmunology & Multiple Sclerosis, 1994 - 1996
  • Virginia Commonwealth University Health System
    Virginia Commonwealth University Health SystemResidency, Neurology, 1990 - 1994
  • Wyckoff Heights Medical Center
    Wyckoff Heights Medical CenterInternship, Preliminary Year, 1989 - 1990
  • Philadelphia College of Osteopathic Medicine
    Philadelphia College of Osteopathic MedicineClass of 1989, D.O.
  • New York Institute of Technology
    New York Institute of TechnologyB.S., Life Sciences, Summa Cum Laude, 1981 - 1985

Certifications & Licensure

  • NV State Medical License
    NV State License 2018 - 2024
  • CA State Medical License
    CA State License 2002 - 2024
  • WA State Medical License
    WA State License 2007 - 2010
  • MA State Medical License
    MA State License 1994 - 2003

Awards, Honors, & Recognition

  • Top Doctors-Inland Empire 2014
  • CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011
  • Partner’s Award in Excellence 2000
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis  
    Chen JA, Barkoff F, Comi G, TRANSFORMS Study Group-Olek MJ, NEJM, 1/4/2010
  • Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis  
    Radue EW, Stuart WH, Calabresi PA, SENTINEL Investigators-Olek MJ, J Neurol Sci, 1/1/2010
  • Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis  
    Zhang Y, Da RR, Guo W, Ren HM, Hilgenberg LG, Sobel RA, Tourtellotte WW, Smith MA, Olek M, Gupta S, Robertson RT, Nagra R, Van Den Noort S, Qin Y., J Clin Immunol, 1/1/2005
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Factors that influence compliance with disease-modifying therapy in multiple sclerosis
    Treadaway K, Hawker K, Racke M, Olek M, Brannon K, Morrison A, Remington G, Frohman E, 21st Congress of ECTRIMS, Thessaloniki, Greece, 1/1/2005
  • A study of B-cell clonal expansion in the cerebral spinal fluid of patients with clinically isolated syndromes suggestive of MS. A diagnostic application
    Qin Y, Duquettte P, Olek MJ, Da RR, Zhang Y, van den Noort S, Honolulu, HI, 1/1/2003
  • Correlations between immunologic markers and MRI measures of disease activity in patients with multiple sclerosis
    Makhlouk K, Guttmann CG, Hohol MJ, Cook S, Olek MJ, Weiner HL, Khoury SJ, AAN, Denver, CO, 1/1/2002
  • Join now to see all

Lectures

  • New Formulation of Copaxone 
    Corona, CA - 1/23/2016
  • LLU Neuroscience Symposium-MS or NOT 
    Loma Linda, CA - 1/16/2016
  • NMSS Patient Conference 
    Loma Linda, CA - 1/14/2015
  • Join now to see all

Other

Press Mentions

  • Modeling Study Suggests That Schools Can Safely Reopen with Proper Mitigation Strategies
    Modeling Study Suggests That Schools Can Safely Reopen with Proper Mitigation StrategiesJune 7th, 2021
  • Symposium on Headache and Related
    Symposium on Headache and RelatedJune 28th, 2020